##common.pageHeaderLogo.altText##
DOI:
https://doi.org/10.57187/5069

Original article

Vol. 156 No. 6 (2026)

Trends in health- and lifestyle-related aspects in women of childbearing age: analysis of Swiss Health Survey data between 1992 and 2022

Cite this as:
Swiss Med Wkly. 2026;156:5069
Published
17.06.2026

Summary

OBJECTIVE: Changes in societal lifestyle trends can influence women’s health and alter their risk profile. In women of childbearing age, this can affect their pregnancy outcomes and the health of their future children. However, limited data exist on how health status, medication use and drug consumption in women of childbearing age in Switzerland have evolved over recent decades. The aim of the study was to provide a comprehensive overview of the health status and lifestyle changes of the young female Swiss population over the past 30 years.

METHODS: Data from all seven nationwide Swiss Health Surveys conducted every five years by the Federal Statistical Office were analysed. Various health- and lifestyle-related variables were selected while focusing on reproductive women aged 15 to 49 years. Results were calculated as either frequencies in percentage or means with 95% confidence intervals. All statistics were conducted using IBM SPSS with a design-based approach, applying weights to align with the sociodemographic distribution of the Swiss population.

RESULTS: Over the past three decades (1992–2022), female participants in the Swiss Health Surveys exhibited increasing educational attainment (rising from 5.4% to 35.9% earning a university degree) and employment rate (from 63.3% to 82.6% employed). Other sociodemographic characteristics remained relatively stable. Health self-ratings improved: the proportion of women reporting “very good” health increased from 31.4% in 1992 to 46.2% in 2022. The prevalence of severe physical symptoms and chronic medical conditions increased over time, with modest rises in the diagnoses of hypertension, hyperchosterolaemia and diabetes. Concerning the use of healthcare services, complementary medicine has experienced a notable increase in usage, with a 28.1% rise in the number of participants reporting its use. Psychological health consultations and treatment for mental health disorders more than doubled during the study period. Focusing on lifestyle factors, the mean body mass index (BMI) increased from 21.7 to 23.2, reflecting a higher prevalence of overweight and obesity. Physical activity levels increased modestly, particularly in moderate-intensity activities, while medication use rose by 18 percentage points. Although the proportion of participants using contraception remained stable at around 70%, the use of oral contraceptives decreased by 27.5 percentage points, while the use of intrauterine devices and condoms steadily increased. Alcohol consumption patterns showed a general decline in both the frequency and absolute daily amount consumed. Tobacco use decreased overall, with a marked reduction in cigarette consumption. Conversely, the use of illicit substances, particularly cannabis, showed an upward trend.

CONCLUSIONS: In Switzerland, the population of women of childbearing age has undergone marked changes in terms of educational attainment and employment rates over the last 30 years. An increase in physiological and psychological diagnoses, alongside the increasing prevalence of cardiovascular risk factors such as high BMI, high cholesterol and diabetes, raise growing concerns. Preventive efforts and counselling seem to have led to positive outcomes in promoting a higher level of nutritional awareness and physical activity as well as in reducing smoking and alcohol consumption. Emerging challenges, however, represent new risks to women’s health. In particular, new smoking products and increased drug consumption deserve the attention of future research. Overall, the observed developments underscore the importance of addressing the health of women of childbearing age, ensuring that they have the necessary support to conceive with minimal risk factors.

References

  1. 1. Joynt Maddox KE, Elkind MS, Aparicio HJ, Commodore-Mensah Y, de Ferranti SD, Dowd WN, et al.; American Heart Association. Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association. Circulation. 2024 Jul;150(4):e65–88. doi: https://doi.org/10.1161/CIR.0000000000001256
  2. 2. Teo KK, Rafiq T. Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries. Can J Cardiol. 2021 May;37(5):733–43. doi: https://doi.org/10.1016/j.cjca.2021.02.009
  3. 3. Nedkoff L, Briffa T, Zemedikun D, Herrington S, Wright FL. Global Trends in Atherosclerotic Cardiovascular Disease. Clin Ther. 2023 Nov;45(11):1087–91. doi: https://doi.org/10.1016/j.clinthera.2023.09.020
  4. 4. Ramlakhan KP, Johnson MR, Roos-Hesselink JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol. 2020 Nov;17(11):718–31. doi: https://doi.org/10.1038/s41569-020-0390-z
  5. 5. Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin. 2012 Aug;30(3):317–29. doi: https://doi.org/10.1016/j.ccl.2012.05.004
  6. 6. Morton A. Physiological Changes and Cardiovascular Investigations in Pregnancy. Heart Lung Circ. 2021;30(1):e6–15. doi: https://doi.org/10.1016/j.hlc.2020.10.001
  7. 7. Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):914–9. doi: https://doi.org/10.1016/0002-9378(91)90438-W
  8. 8. Bundesamt für Statistik [Federal Statistical Office]. (2022). Demografisches Porträt der Schweiz: Bestand, Struktur und Entwicklung der Bevölkerung im Jahr 2020. Retrieved from https://www.bfs.admin.ch/bfs/de/home/aktuell/neue-veroeffentlichungen.assetdetail.21764558.html
  9. 9. Laopaiboon M, Lumbiganon P, Intarut N, Mori R, Ganchimeg T, Vogel JP, et al.; WHO Multicountry Survey on Maternal Newborn Health Research Network. Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG. 2014 Mar;121(s1 Suppl 1):49–56. doi: https://doi.org/10.1111/1471-0528.12659
  10. 10. Lockwood CJ. Prenatal care: Patient education, health promotion, and safety of commonly used drugs. 2025. Available from www.uptodate.com
  11. 11. Agarwal P, Morriseau TS, Kereliuk SM, Doucette CA, Wicklow BA, Dolinsky VW. Maternal obesity, diabetes during pregnancy and epigenetic mechanisms that influence the developmental origins of cardiometabolic disease in the offspring. Crit Rev Clin Lab Sci. 2018 Mar;55(2):71–101. doi: https://doi.org/10.1080/10408363.2017.1422109
  12. 12. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005 Mar;115(3):e290–6. doi: https://doi.org/10.1542/peds.2004-1808
  13. 13. Bornhauser C, Quack Lötscher K, Seifert B, Simões-Wüst AP. Diet, medication use and drug intake during pregnancy: data from the consecutive Swiss Health Surveys of 2007 and 2012. Swiss Med Wkly. 2017 Dec;147:w14572.
  14. 14. Coleman-Cowger VH, Schauer GL, Peters EN. Marijuana and tobacco co-use among a nationally representative sample of US pregnant and non-pregnant women: 2005-2014 National Survey on Drug Use and Health findings. Drug Alcohol Depend. 2017 Aug;177:130–5. doi: https://doi.org/10.1016/j.drugalcdep.2017.03.025
  15. 15. Bergmann KE, Bergmann RL, Ellert U, Dudenhausen JW. Perinatale Einflussfaktoren auf die spätere Gesundheit. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS) [Perinatal risk factors for long-term health. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(5-6):670–6. doi: https://doi.org/10.1007/s00103-007-0228-4
  16. 16. Krischer BB, Hösli I, Renteria S, Streuli I, Surbek D. (2025). Präkonzeptionsberatung – “Preconception Care”. Retrieved from https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/De/92_Expertenbrief_Praekonzeptionsberatung_ersetzt_EB33_250620.pdf
  17. 17. Dratva JG, Späth A, Zemp Stutz E. (2014). SWIFS – Swiss Infant Feeding Study: Eine nationale Studie zur Säuglingsernährung und Gesundheit im ersten Lebensjahr Retrieved from Basel: https://www.swisstph.ch/fileadmin/user_upload/SwissTPH/Projects/SWIFS/SWIFS_Schlussbericht.pdf
  18. 18. Stephenson J, Heslehurst N, Hall J, Schoenaker DA, Hutchinson J, Cade JE, et al. Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health. Lancet. 2018 May;391(10132):1830–41. doi: https://doi.org/10.1016/S0140-6736(18)30311-8
  19. 19. Bundesamt für Statistik [Federal Statistical Office] (2023). Die Schweizerische Gesundheitsbefragung 2022 in Kürze. Konzept, Methode, Durchführung. Retrieved from https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/erhebungen/sgb.assetdetail.31646339.html
  20. 20. Hänsel M, Steigmiller K, Luft AR, Gebhard C, Held U, Wegener S. Neurovascular disease in Switzerland: 10-year trends show non-traditional risk factors on the rise and higher exposure in women. Eur J Neurol. 2022 Sep;29(9):2851–60. doi: https://doi.org/10.1111/ene.15434
  21. 21. West BT. Statistical and methodological issues in the analysis of complex sample survey data: practical guidance for trauma researchers. J Trauma Stress. 2008 Oct;21(5):440–7. doi: https://doi.org/10.1002/jts.20356
  22. 22. Bundesamt für Statistik [Federal Statistical Office] (2023). Die Schweizerische Gesundheitsbefragung 2022 in Kürze. Konzept, Methode, Durchführung. Retrieved from https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/erhebungen/sgb.assetdetail.31646339.html
  23. 23. Vitale C, Fini M, Spoletini I, Lainscak M, Seferovic P, Rosano GM. Under-representation of elderly and women in clinical trials. Int J Cardiol. 2017 Apr;232:216–21. doi: https://doi.org/10.1016/j.ijcard.2017.01.018
  24. 24. Buchmann MC, Sacchi S. Labour market structures and women’s employment levels. Work Employ Soc. 2010;24(2):279–99. doi: https://doi.org/10.1177/0950017010362142
  25. 25. Bundesamt für Statistik [Federal Statistical Office]. (2023). SAKE in Kürze 2023 - Schweizerische Arbeitskräfteerhebung. Retrieved from www.statistik.ch
  26. 26. Booth AL, van Ours JC. Part-time jobs: what women want? J Popul Econ. 2013;26(1):263–83. doi: https://doi.org/10.1007/s00148-012-0417-9
  27. 27. Mills M, Rindfuss RR, McDonald P, te Velde E; ESHRE Reproduction and Society Task Force. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update. 2011;17(6):848–60. doi: https://doi.org/10.1093/humupd/dmr026
  28. 28. Waldenström U. Postponing parenthood to advanced age. Ups J Med Sci. 2016 Nov;121(4):235–43. doi: https://doi.org/10.1080/03009734.2016.1201553
  29. 29. Szcześniak M, Timoszyk-Tomczak C, Łoś J, Grzeczka M. Future anxiety and the motives for postponing parenthood: generational time perspective and life satisfaction as mediators. Front Psychol. 2025 Feb;15:1441927. doi: https://doi.org/10.3389/fpsyg.2024.1441927
  30. 30. Martin JA, Hamilton BE, Osterman MJ, Driscoll AK. Births: final Data for 2018. Natl Vital Stat Rep. 2019 Nov;68(13):1–47.
  31. 31. Easton S, Morton K, Tappy Z, Francis D, Dennison L. Young People’s Experiences of Viewing the Fitspiration Social Media Trend: qualitative Study. J Med Internet Res. 2018 Jun;20(6):e219. doi: https://doi.org/10.2196/jmir.9156
  32. 32. Bhor N, Nadh PO. Interfaces of ‘being healthy and being Ill’: how is health being perceived by individuals with non-communicable chronic conditions? Int J Equity Health. 2024 May;23(1):108. doi: https://doi.org/10.1186/s12939-024-02188-2
  33. 33. Bluthochdruck (Alter: 15+). Schweizer Monitoring-System Sucht und nichtübertragbare Krankheiten (MonAM). Available from https://ind.obsan.admin.ch/indicator/monam/bluthochdruck-alter-15
  34. 34. Erhöhter Cholesterinspiegel. Schweizer Monitoring-System Sucht und nichtübertragbare Krankheiten (MonAM). Available from https://ind.obsan.admin.ch/indicator/monam/erhoehter-cholesterinspiegel-alter-15
  35. 35. Zhou B, Rayner AW, Gregg EW, Sheffer KE, Carrillo-Larco RM, Bennett JE, et al.; NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024 Nov;404(10467):2077–93. doi: https://doi.org/10.1016/S0140-6736(24)02317-1
  36. 36. Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017 Mar;40(3):213–20. doi: https://doi.org/10.1038/hr.2016.126
  37. 37. Orecchio A, Periard D, Kashef A, Magnin JL, Hayoz D, Fontana E. Incidence of gestational diabetes and birth complications in Switzerland: screening in 1042 pregnancies. Gynecol Endocrinol. 2014 Aug;30(8):561–4. doi: https://doi.org/10.3109/09513590.2013.879853
  38. 38. Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. BMJ. 2023 Jun;381:e071653. doi: https://doi.org/10.1136/bmj-2022-071653
  39. 39. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) e. V. ÖGfGuGO, Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe (SGGG), u. a. (2024). Hypertensive Erkrankungen in der Schwangerschaft (HES) – Diagnostik und Therapie. S2k-Leitlinie der DGGG, OEGGG und SGGG (AWMF-Registernummer 015/018). Retrieved from https://register.awmf.org/assets/guidelines/015-018l_S2k_Hypertensive-Erkrankungen-Schwangerschaft-HES-Diagnostik-Therapie_2024-07.pdf
  40. 40. Chen P, Wang S, Ji J, Ge A, Chen C, Zhu Y, et al. Risk factors and management of gestational diabetes. Cell Biochem Biophys. 2015 Mar;71(2):689–94. doi: https://doi.org/10.1007/s12013-014-0248-2
  41. 41. L M. (2024). Grundwissen SwissDRG und Glossar. Retrieved from https://www.sgaim.ch/fileadmin/user_upload/Blogartikel_01_Grundwissen_SwissDRG_Einleitung_und_Glossar_als_PDF.pdf
  42. 42. Tangkiatkumjai M, Boardman H, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther. 2020 Nov;20(1):363. doi: https://doi.org/10.1186/s12906-020-03157-2
  43. 43. Klein SD, Torchetti L, Frei-Erb M, Wolf U. Usage of Complementary Medicine in Switzerland: Results of the Swiss Health Survey 2012 and Development Since 2007. PLoS One. 2015 Oct;10(10):e0141985. doi: https://doi.org/10.1371/journal.pone.0141985
  44. 44. Meier-Girard D, Lüthi E, Rodondi PY, Wolf U. Prevalence, specific and non-specific determinants of complementary medicine use in Switzerland: Data from the 2017 Swiss Health Survey. PLoS One. 2022 Sep;17(9):e0274334. doi: https://doi.org/10.1371/journal.pone.0274334
  45. 45. Bundesamt für Statistik [Federal Statistical Office]. (2025). Schweizerische Gesundheitsbefragung 2022 - Gesundheit und Geschlecht. Retrieved from www.statistik.ch
  46. 46. Martino HR, Koch U, Attinger-Andreoli Y, Michel K, Gassmann J, Berger S, et al. (2012). Arbeitspapier Entstigmatisierung: Grundlagen für eine nationale Kampagne zur Entstigmatisierung von psychischen Krankheiten und von Menschen mit Störungen der psychischen Gesundheit. Retrieved from https://public-health.ch/documents/232/Entstigmatisierung_Arbeitspapier_DEF.pdf
  47. 47. Marengoni A, Rizzuto D, Fratiglioni L, Antikainen R, Laatikainen T, Lehtisalo J, et al. The Effect of a 2-Year Intervention Consisting of Diet, Physical Exercise, Cognitive Training, and Monitoring of Vascular Risk on Chronic Morbidity-the FINGER Randomized Controlled Trial. J Am Med Dir Assoc. 2018 Apr;19(4):355–360.e1. doi: https://doi.org/10.1016/j.jamda.2017.09.020
  48. 48. (WHO) WHO. (2018). Noncommunicable diseases country profiles 2018. Retrieved from https://iris.who.int/handle/10665/274512
  49. 49. Stubert J, Reister F, Hartmann S, Janni W. The Risks Associated With Obesity in Pregnancy. Dtsch Arztebl Int. 2018 Apr;115(16):276–83. doi: https://doi.org/10.3238/arztebl.2018.0276
  50. 50. Agarwal P, Morriseau TS, Kereliuk SM, Doucette CA, Wicklow BA, Dolinsky VW. Maternal obesity, diabetes during pregnancy and epigenetic mechanisms that influence the developmental origins of cardiometabolic disease in the offspring. Crit Rev Clin Lab Sci. 2018 Mar;55(2):71–101. doi: https://doi.org/10.1080/10408363.2017.1422109
  51. 51. Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017 Feb;356:j1. doi: https://doi.org/10.1136/bmj.j1
  52. 52. Vandenbosch L, Fardouly J, Tiggemann M. Social media and body image: recent trends and future directions. Curr Opin Psychol. 2022 Jun;45:101289. doi: https://doi.org/10.1016/j.copsyc.2021.12.002
  53. 53. Revranche M, Biscond M, Husky MM. Lien entre usage des réseaux sociaux et image corporelle chez les adolescents : une revue systématique de la littérature [Investigating the relationship between social media use and body image among adolescents: A systematic review]. Encephale. 2022 Apr;48(2):206–18. doi: https://doi.org/10.1016/j.encep.2021.08.006
  54. 54. Leitzmann C. Vegetarian nutrition: past, present, future. Am J Clin Nutr. 2014 Jul;100 Suppl 1:496S–502S. doi: https://doi.org/10.3945/ajcn.113.071365
  55. 55. Welch N, McNaughton SA, Hunter W, Hume C, Crawford D. Is the perception of time pressure a barrier to healthy eating and physical activity among women? Public Health Nutr. 2009 Jul;12(7):888–95. doi: https://doi.org/10.1017/S1368980008003066
  56. 56. Willer HL, editor. (2015). The World of Organic Agriculture: Statistics and Emerging Trends 2015. Frick and Bonn: Research Institute of Organic Agriculture (FiBL) and IFOAM – Organics International.
  57. 57. Carey RM, Moran AE, Whelton PK. Treatment of Hypertension: A Review. JAMA. 2022 Nov;328(18):1849–61. doi: https://doi.org/10.1001/jama.2022.19590
  58. 58. Bundesärztekammer (BÄK) KBK, Arbeitsgemeinschaft der Wissenschaftlichen Medizini, (AWMF) sF. (2023). Nationale VersorgungsLeitlinie Hypertonie – Kurzfassung, Version 1.0 (AWMF-Register-Nr. nvl-009). Retrieved from www.leitlinien.de/hypertonie
  59. 59. Rosemann AR, Beise U, Huber F. (2020). Dyslipidämie. Retrieved from https://www.hausarztmedizin.uzh.ch/dam/jcr:2d09551e-e3a9-4c54-8f11-aa926f3bb3c8/IHAMZ-Guidelines_Dyslipid%C3%A4mie.pdf
  60. 60. Giani AS, Schönberger J. (2019). Guideline Hyperlipidämie im Kontext des kardiovaskulären Risikos von Erwachsenen bis zum 65. Lebensjahr. Retrieved from https://www.mednetbern.ch/publications/hyperlipidaemie-guideline.pdf
  61. 61. Hösli IA, Althof G, Brändle M, Hamza A, Honegger C, Jornayvaz F, et al. (2023). Screening und Management der Gestationsdiabetes Retrieved from https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/De/81_Screening_und_Management_der_Gestationsdiabetes_deutsch.pdf
  62. 62. Dłuski DF, Ruszała M, Rudziński G, Pożarowska K, Brzuszkiewicz K, Leszczyńska-Gorzelak B. Evolution of Gestational Diabetes Mellitus across Continents in 21st Century. Int J Environ Res Public Health. 2022 Nov;19(23):15804. doi: https://doi.org/10.3390/ijerph192315804
  63. 63. Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs. Int J Environ Res Public Health. 2021 May;18(11):5530. doi: https://doi.org/10.3390/ijerph18115530
  64. 64. Bäckryd E. Gender differences in dispensed analgesics in Sweden during 2006-2015 - an observational, nationwide, whole-population study. Int J Womens Health. 2018 Jan;10:55–64. doi: https://doi.org/10.2147/IJWH.S142052
  65. 65. Azami-Aghdash S, Mohseni M, Etemadi M, Royani S, Moosavi A, Nakhaee M. Prevalence and Cause of Self-Medication in Iran: A Systematic Review and Meta-Analysis Article. Iran J Public Health. 2015 Dec;44(12):1580–93.
  66. 66. Martella M, Minutiello E, Gianino MM. Patterns of Antidepressant and Anxiolytic Use and Spending in 14 European Countries (2012-2021): A Comprehensive Time Series Analysis. Health Serv Insights. 2024 Oct;17:11786329241282526. doi: https://doi.org/10.1177/11786329241282526
  67. 67. Bystritsky A, Khalsa SS, Cameron ME, Schiffman J. Current diagnosis and treatment of anxiety disorders. P&T. 2013 Jan;38(1):30–57.
  68. 68. Bandelow B, Werner AM, Kopp I, Rudolf S, Wiltink J, Beutel ME. The German Guidelines for the treatment of anxiety disorders: first revision. Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):571–82. doi: https://doi.org/10.1007/s00406-021-01324-1
  69. 69. Seifritz EH, Hemmeter UM, Bondolfi G, Preisig M, Rennhard S, Hatzinger M, et al. (2024). Die Behandlung der Angsterkrankungen: Panikstörung, Agoraphobie, generalisierte Angststörung, soziale Angststörung, spezifische Phobien. Retrieved from SGAD, SGPP, SGBP, SCAP, SGKJPP: https://www.psychiatrie.ch/fileadmin/SGPP/user_upload/Fachleute/Empfehlungen/240328_Behandlungsempfehlungen_DE.pdf
  70. 70. Hellström A, Gemzell Danielsson K, Kopp Kallner H. Trends in use and attitudes towards contraception in Sweden: results of a nationwide survey. Eur J Contracept Reprod Health Care. 2019 Apr;24(2):154–60. doi: https://doi.org/10.1080/13625187.2019.1581163
  71. 71. Fabunmi OA, Dludla PV, Nkambule BB. Investigating cardiovascular risk in premenopausal women on oral contraceptives: systematic review with meta-analysis. Front Cardiovasc Med. 2023 Apr;10:1127104. doi: https://doi.org/10.3389/fcvm.2023.1127104
  72. 72. Rosano GM, Rodriguez-Martinez MA, Spoletini I, Regidor PA. Obesity and contraceptive use: impact on cardiovascular risk. ESC Heart Fail. 2022 Dec;9(6):3761–7. doi: https://doi.org/10.1002/ehf2.14104
  73. 73. Hannaford P. Cardiovascular events associated with different combined oral contraceptives: a review of current data. Drug Saf. 2000 May;22(5):361–71. doi: https://doi.org/10.2165/00002018-200022050-00004
  74. 74. Highly effective copper IUD will hit U.S. market in 1988. Contracept Technol Update. 1987 Dec;8(12):149–52.
  75. 75. Lyus R, Lohr P, Prager S; Board of the Society of Family Planning. Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women. Contraception. 2010 May;81(5):367–71. doi: https://doi.org/10.1016/j.contraception.2010.01.010
  76. 76. Lohr PA, Lyus R, Prager S. Use of intrauterine devices in nulliparous women. Contraception. 2017 Jun;95(6):529–37. doi: https://doi.org/10.1016/j.contraception.2016.08.011
  77. 77. Committee Opinion No. Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy. Obstet Gynecol. 2015 Oct;126(4):e44–8. doi: https://doi.org/10.1097/AOG.0000000000001106
  78. 78. Bastow B, Sheeder J, Guiahi M, Teal S. Condom use in adolescents and young women following initiation of long- or short-acting contraceptive methods. Contraception. 2018 Jan;97(1):70–5. doi: https://doi.org/10.1016/j.contraception.2017.10.002
  79. 79. Evans WD, Ulasevich A, Hatheway M, Deperthes B. Systematic Review of Peer-Reviewed Literature on Global Condom Promotion Programs. Int J Environ Res Public Health. 2020 Mar;17(7):2262. doi: https://doi.org/10.3390/ijerph17072262
  80. 80. Algur E, Wang E, Friedman HS, Deperthes B. A Systematic Global Review of Condom Availability Programs in High Schools. J Adolesc Health. 2019 Mar;64(3):292–304. doi: https://doi.org/10.1016/j.jadohealth.2018.11.013
  81. 81. Bundesamt für Statistik [Federal Statistical Office]<. (2024). Schweizerische Gesundheitsbefragung - Alkoholkonsum von 1992 bis 2022. Retrieved from www.statistik.ch
  82. 82. Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017 Sep;74(9):911–23. doi: https://doi.org/10.1001/jamapsychiatry.2017.2161
  83. 83. Mårdby AC, Lupattelli A, Hensing G, Nordeng H. Consumption of alcohol during pregnancy-A multinational European study. Women Birth. 2017 Aug;30(4):e207–13. doi: https://doi.org/10.1016/j.wombi.2017.01.003
  84. 84. Popova S, Lange S, Probst C, Gmel G, Rehm J. Global prevalence of alcohol use and binge drinking during pregnancy, and fetal alcohol spectrum disorder. Biochem Cell Biol. 2018 Apr;96(2):237–40. doi: https://doi.org/10.1139/bcb-2017-0077
  85. 85. Flak AL, Su S, Bertrand J, Denny CH, Kesmodel US, Cogswell ME. The association of mild, moderate, and binge prenatal alcohol exposure and child neuropsychological outcomes: a meta-analysis. Alcohol Clin Exp Res. 2014 Jan;38(1):214–26. doi: https://doi.org/10.1111/acer.12214
  86. 86. Hammer R, Rapp E. Women’s views and experiences of occasional alcohol consumption during pregnancy: A systematic review of qualitative studies and their recommendations. Midwifery. 2022 Aug;111:103357. doi: https://doi.org/10.1016/j.midw.2022.103357
  87. 87. Amos A, Haglund M. From social taboo to “torch of freedom”: the marketing of cigarettes to women. Tob Control. 2000 Mar;9(1):3–8. doi: https://doi.org/10.1136/tc.9.1.3
  88. 88. Carpenter CM, Wayne GF, Connolly GN. Designing cigarettes for women: new findings from the tobacco industry documents. Addiction. 2005 Jun;100(6):837–51. doi: https://doi.org/10.1111/j.1360-0443.2005.01072.x
  89. 89. Bundesamt für Statistik [Federal Statistical Office]. (2020). Schweizerische Gesundheitsbefragung 2017 - Gesundheit und Geschlecht [Swiss Health Survey 2017: health and gender]. Retrieved from https://www.bfs.admin.ch/bfs/en.assetdetail.15284969.html
  90. 90. Meienberg AM, Vischer A, et al. Smoking prevention in adolescents: a cross- sectional and qualitative evaluation of a newly implemented prevention program in Switzerland. BMJ Open. 2021;11(12):e048319. doi: https://doi.org/10.1136/bmjopen-2020-048319
  91. 91. S H. Swiss Smoking Prevention Policies. Network Management and Governance in Policy Implementation: The Case of Smoking Prevention Programs. Cham: Springer International Publishing; 2022.
  92. 92. Jandíková H, Dušková M, Stárka L. The influence of smoking and cessation on the human reproductive hormonal balance. Physiol Res. 2017 Sep;66 Suppl 3:S323–31. doi: https://doi.org/10.33549/physiolres.933724
  93. 93. Hamadneh S, Hamadneh J. Active and Passive Maternal Smoking During Pregnancy and Birth Outcomes: A Study From a Developing Country. Ann Glob Health. 2021 Dec;87(1):122. doi: https://doi.org/10.5334/aogh.3384
  94. 94. Lange S, Probst C, Rehm J, Popova S. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Health. 2018 Jul;6(7):e769–76. doi: https://doi.org/10.1016/S2214-109X(18)30223-7
  95. 95. Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011 Dec;106(12):2110–21. doi: https://doi.org/10.1111/j.1360-0443.2011.03565.x
  96. 96. Health NCfCDPaHPUOoSa. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta (GA). US: Centers for Disease Control and Prevention; 2016.
  97. 97. Cannabis Regulation in Europe: Country Report Switzerland. Retrieved from https://www.tni.org